These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 16919315

  • 1. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 3. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 4. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 5. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B.
    Cancer; 2005 Apr 15; 103(8):1631-43. PubMed ID: 15742334
    [Abstract] [Full Text] [Related]

  • 6. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
    Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC.
    Cancer; 2004 May 15; 100(10):2139-47. PubMed ID: 15139056
    [Abstract] [Full Text] [Related]

  • 7. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
    Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R.
    Gynecol Oncol; 2007 Feb 15; 104(2):311-9. PubMed ID: 17030350
    [Abstract] [Full Text] [Related]

  • 8. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.
    Oncol Rep; 2004 Jun 15; 11(6):1153-9. PubMed ID: 15138549
    [Abstract] [Full Text] [Related]

  • 9. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W.
    Gynecol Oncol; 2001 Aug 15; 82(2):291-8. PubMed ID: 11531282
    [Abstract] [Full Text] [Related]

  • 10. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
    Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B.
    Gynecol Oncol; 2013 May 15; 129(2):358-63. PubMed ID: 23438671
    [Abstract] [Full Text] [Related]

  • 11. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 15; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 12. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
    Davidson B, Trope' CG, Wang TL, Shih IeM.
    Gynecol Oncol; 2006 Dec 15; 103(3):814-9. PubMed ID: 16844205
    [Abstract] [Full Text] [Related]

  • 13. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK, Chao TK, Yu CP, Yu MH, Jin JS.
    APMIS; 2009 Mar 15; 117(3):162-75. PubMed ID: 19245589
    [Abstract] [Full Text] [Related]

  • 14. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.
    Garzetti GG, Ciavattini A, Lucarini G, Goteri G, de e Nictolis M, Garbisa S, Masiero L, Romanini C, Graziella B.
    Anticancer Res; 1995 Mar 15; 15(6B):2799-804. PubMed ID: 8669868
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
    Torng PL, Mao TL, Chan WY, Huang SC, Lin CT.
    Gynecol Oncol; 2004 Feb 15; 92(2):559-67. PubMed ID: 14766248
    [Abstract] [Full Text] [Related]

  • 16. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R.
    Clin Cancer Res; 2003 Apr 15; 9(4):1412-9. PubMed ID: 12684413
    [Abstract] [Full Text] [Related]

  • 17. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
    Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J.
    Hum Pathol; 2011 Jul 15; 42(7):1019-26. PubMed ID: 21315408
    [Abstract] [Full Text] [Related]

  • 18. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
    Clin Cancer Res; 2006 Mar 01; 12(5):1487-93. PubMed ID: 16533772
    [Abstract] [Full Text] [Related]

  • 19. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
    Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R.
    Gynecol Oncol; 2004 May 01; 93(2):517-23. PubMed ID: 15099972
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.
    Oncol Rep; 2003 May 01; 10(1):89-95. PubMed ID: 12469150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.